macrogol solution klean-prep (Klean Industries)
Structured Review

Macrogol Solution Klean Prep, supplied by Klean Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrogol+solution+klean-prep/macrogol+3350/pmc11525118-0-53-56
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials"
Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials
Journal: Frontiers in Pharmacology
doi: 10.3389/fphar.2024.1430724
Figure Legend Snippet: Main characteristics of studies included in the network meta-analysis.
Techniques Used: Infection, Suspension, Enzyme Immunoassay, Polymerase Chain Reaction, Biomarker Discovery, Capsules, Neutralization, Enzyme-linked Immunosorbent Assay
Related Articles
Infection:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , Suspension:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , Enzyme Immunoassay:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , Polymerase Chain Reaction:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , Biomarker Discovery:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , Capsules:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , Neutralization:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , Enzyme-linked Immunosorbent Assay:Article Title: Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Article Snippet: Introduction: Recurrent Clostridiodes difficile infection (rCDI) is a growing public health burden, and is associated with poor patient outcomes.. Fecal microbiota transplantation (FMT) is a novel therapy with an aim to restore the disrupted microbiota with demonstrated success in management of rCDI and a favorable safety profile.. Areas covered: This review includes a comprehensive overview of a search of the literature including epidemiology of rCDI, basics of the gut microbiome, antibiotic therapy for rCDI along with rationale for, safety and efficacy of FMT for rCDI. Article Title: Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials Article Snippet: Van Nood-2013 , Open-label, randomized, controlled trial , Diarrhea (≥3 loose or watery stools per day for at least 2 consecutive days or ≥8 loose stools in 48 h) and a positive stool test for C. difficile toxin , 42 , |
